NCT06055049

Brief Summary

The purpose of this \[study type: a single-blind, placebo-controlled randomization study\] was to determine the effect of kinesio taping on pain, stress, sleep, and quality of life in college students with primary dysmenorrhea. The key question(s) it aims to answer are: • \[Is there a difference between pain, stress, sleep quality and quality of life scores in the post-kinesio taping intervention group and the placebo group?\] Participants \[both groups will come to the laboratory to replace their kinesio bands on the specified dates\] If there is a comparison group: Researchers will compare with the placebo group.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 18, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 26, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

1.2 years

First QC Date

September 18, 2023

Last Update Submit

March 23, 2024

Conditions

Keywords

Dysmenorrhea PrimaryKinesio TapingPainStressSleep QualityQuality of life

Outcome Measures

Primary Outcomes (6)

  • Mcgill Pain Scale

    Mcgill Pain Scale Short Form (MAS-SF) The Mcgill Pain Scale Short Form was developed by Ronald Melzack in 1987 to determine the nature, effect, and overall pain intensity of pain. In the first part of the Mcgill Pain Scale Short Form, there are 15 word groups describing the sensory/perceptual pain dimension (first 11 words) and emotional/emotional pain dimension (last four words). In the second part of the scale, the severity of the pain at that moment is determined from the patient by using the VAS. In the third part of the scale, a six-point Likert type scale is used to determine the general pain intensity. Scale; It consists of expressive values ranging from 0 = no pain, 1 = mild, 2 = bothersome, 3 = distressing, 4 = terrible, 5 = unbearable pain.

    Before the study (Pre-test) 2. End of the application (week 12) 3. Post-test (at the end of the 16. week).

  • VAS pain scale

    Visual Analogue Scale (VAS) Different scales are used in studies to measure the level of pain. In our study, the pain intensity of the participants will be determined by using the Visual Analogue Scale (VAS) in the Determination of Compliance with the Criteria Form. VAS has been developed in order to be able to specify the severity of pain more easily by converting some values that cannot be measured numerically. VAS is a safe, easily applicable measurement tool that has been generally accepted in the world literature for many years. A low score on the VAS indicates low/low pain intensity, and a high score indicates high/severe pain.

    Pre-Study will be applied to determine compliance with the criteria.

  • Menstrual Symptom Questionnaire

    Menstrual Symptom Questionnaire (MSQ) Menstruation Symptom Scale (MSI) It was developed by Chesney and Tasto in 1975 to assess menstrual pain and symptoms . The scale, which is a five-point Likert type and consists of 24 items, was updated by Negriff et al. in 2009 by re-evaluating its factor structure and usability. The MSÖ score is calculated by taking the total mean score of the items in the scale. An increase in the mean score indicates an increase in the severity of menstrual symptoms. The score obtained from the sub-dimensions in the scale is calculated by taking the total score average of the items in the sub-dimensions. An increase in the mean score for the sub-dimensions indicates an increase in the severity of menstrual symptoms related to that sub-dimension.

    Before the study (Pre-test) 2. End of the application (week 12) 3. Post-test (at the end of the 16. week).

  • Adaptation of the Perceived Stress Scale

    Adaptation of the Perceived Stress Scale (Pss-14) The Perceived Stress Level Scale was focused on by Cohen, Kamarck, and Mermelstein in 1983 to determine perceived stress controls. The Turkish validity and reliability study of the scale was conducted by Eskin et al. This 14-item scale reflects the extent to which people perceive purposive stress according to the basic idea in their lives. The scale is 5-point Likert type (0: Never, 1: Almost Never, 2: Sometimes, 3: Often, 4: Very Often). is a scale. One of the questions in the scale is to evaluate the changes in mood in the last month. There are seven items (4, 5, 6, 7, 9, 10 and 13) containing positive statements in the scale and these items are scored in reverse. The stress level perceived by the respondent is determined by adding the scores obtained from the items. A score between 0-56 points is taken in the scale. The higher the score, the higher the perceived stress level. The Cronbach Alpha Coefficient of the scale is 0.84.

    Before the study (Pre-test) 2. End of the application (week 12) 3. Post-test (at the end of the 16. week).

  • Pittsburgh Sleep Quality Index

    Pittsburgh Sleep Quality Index (PUKI) PSQI assesses sleep quality over the past month. 19 out of 24 questions in PSQI are self-report questions. Five questions are answered by the spouse or roommate. The last five questions are for clinical information purposes only and are not included in the scoring. Self-report questions involve several factors related to sleep quality. These relate to the estimation of sleep duration, sleep latency, and the frequency and severity of certain sleep-related problems. Subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleeping pills, and daytime dysfunction were divided into 18 items included in the scoring. Each item is evaluated over 0-3 points. As the total score obtained from the scale increases, sleep quality decreases. Patients with a total score of 0-4 on PUKI are classified as having good sleep quality. Scale scores of 5 and above indicate poor sleep quality.

    Before the study (Pre-test) 2. End of the application (week 12) 3. Post-test (at the end of the 16. week).

  • World Health Organization Quality of Life Scale Short Form

    World Health Organization Quality of Life Scale (WHOQOL-BREF-TR) The World Health Organization Quality of Life Scale-Short Form was developed by the World Health Organization (WHO) in 1998 to assess the quality of life of individuals. The Turkish validity and reliability studies of the scale were carried out by Eser et al. WHOQOL-BREF-TR consists of 27 questions and item 27 is not usually included in statistical analysis. The scale does not have a total score, each dimension is evaluated within itself. The scores of the dimensions are evaluated between 4-20. Increasing score indicates goodness.

    Before the study (Pre-test) 2. End of the application (week 12) 3. Post-test (at the end of the 16. week).

Study Arms (2)

Kinesio Taping (n=28)

EXPERIMENTAL

Kinesio taping certified researcher Y.S. It will be implemented by. Kinesio Taping will be applied to the study group participants during three menstrual cycles. Kinesio taping will be done face to face by the researcher in the laboratory. The participants were given the "Mcgill Pain Scale Short Form", "Menstruation Symptom Scale", "Perceived Stress Scale", "Pittsburgh Sleep Quality Index" and "World Health Organization Quality of Life Scale-Short Form (WHOQOL-BREF-TR) " immediately after the third cycle and the fourth cycle without treatment. will be applied. The follow-up of the implementation process will be recorded with the MSF and KBIF prepared by the researcher. Kinesio tapes will be applied to the sacral area with 100% tension twice a week, starting from the first start of menstruation. It will continue like this until the end of the 3rd period of menstruation.

Other: Intervention (Kinesio Taping) group

Sham Taping (n=28)

PLACEBO COMPARATOR

Sham taping (fake or tensionless kinesio taping) will be applied to students in the placebo group. The quality of the kinesio tape used in sham taping will be the same. "Mcgill Pain Scale Short Form", "Menstruation Symptom Scale", "Perceived Stress Scale", "Pittsburgh Sleep Quality Index" and "World Health Organization Quality of Life Scale-Short Form (WHOQOL-BREF-TR) administered to participants in the placebo group before the first session )" will be refilled at the end of the third cycle and at the end of the fourth cycle without treatment. In order to eliminate the ethical problems that may occur in the control group, kinesio taping will be applied to the participants in this group after the data collection process of the research is completed. Kinesio tapes will be applied to the sacral area without tension, twice a week, starting from the first start of menstruation. This situation will continue until the end of the 3rd menstrual period.

Other: Intervention (Kinesio Taping) group

Interventions

It is the group to which Kinesio Taping applied.

Kinesio Taping (n=28)Sham Taping (n=28)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe female just have dysmenhorea
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • over 18 years old,
  • st grade student
  • Willing to participate in the research,
  • Open to communication,
  • Having a regular menstrual period (occurring at intervals of 21-35 days and lasting 3-8 days),
  • Menstrual pain severity is at least 4 according to the Visual Pain Scale,
  • A score of 60 or more on the Menstruation Symptom Scale,
  • Not using hormonal contraception and intrauterine device,
  • Not pregnant and not experiencing pregnancy before,
  • Does not have a systemic and chronic disease,
  • Have not had a gynecological disorder or surgical operation before,
  • Not using analgesics 6 hours before and during the study period,
  • Not regularly applying kinesio taping,
  • Students without psychiatric problems.

You may not qualify if:

  • under the age of 18,
  • Studying in the 2nd grade,
  • Not willing to participate in the research,
  • Closed to communication,
  • Not having a regular menstrual period (not occurring at intervals of 21-35 days and lasting more or less than 3-8 days),
  • Menstrual pain severity is less than 4 according to the Visual Pain Scale,
  • A score below 60 on the Menstruation Symptom Scale,
  • Using hormonal contraception and intrauterine device,
  • who are pregnant and have experienced pregnancy before,
  • Having a systemic and chronic disease,
  • Having had a gynecological disorder or surgical operation before,
  • Using analgesics 6 hours before and during the study period,
  • Regularly applying kinesio taping, Students with psychiatric problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mersin University

Mersin, Yenişehir, 33343, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

PainSleep Initiation and Maintenance Disorders

Interventions

MethodsPopulation Groups

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Investigative TechniquesDemographyPopulation Characteristics

Study Officials

  • Duygu VEFIKULUCAY YILMAZ, Prof

    Mersin University Faculty of Nursing

    STUDY CHAIR
  • Yagmur SURMELI, Lect.

    Mersin University Faculty of Nursing

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Duygu VEFIKULUCAY YILMAZ, Prof

CONTACT

Yagmur SURMELI, Lect.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: There will be 2 groups (kinesio taping and sham taping) and each group will consist of at least 28 people.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

September 18, 2023

First Posted

September 26, 2023

Study Start

May 1, 2023

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

March 26, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations